SCHEMBL22858905

SCHEMBL22858905

Cc1cc(Br)ccc1C(=O)N(C)CC1CCOC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.41
GAA P10253 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
NSD2 O96028 1/20 0.41
OXTR P30559 2/20 0.38
AVPR1A P37288 2/20 0.38
CNR1 P21554 2/20 0.37
CNR2 P34972 2/20 0.37
EED O75530 1/20 0.36
PARP1 P09874 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
KCNK3 O14649 1/20 0.34
UTS2R Q9UKP6 1/20 0.34
SLC2A1 P11166 1/20 0.33
SLC2A2 P11168 1/20 0.33
SLC2A3 P11169 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22858909 1.00 NPC1 (0.41) NPC1GAARAB9AKMT2ANSD2
SCHEMBL22858726 0.84 NSD2 (0.50) NPC1GAARAB9AKMT2ANSD2
SCHEMBL22922380 0.84 NSD2 (0.50) NPC1GAARAB9AKMT2ANSD2
SCHEMBL22858730 0.84 NSD2 (0.50) NPC1GAARAB9AKMT2ANSD2
SCHEMBL22858733 0.79 NPC1 (0.38) NPC1GAARAB9AKMT2ANSD2
SCHEMBL22858734 0.79 NPC1 (0.38) NPC1GAARAB9AKMT2ANSD2
SCHEMBL25013007 0.78 NPC1 (0.47) NPC1GAARAB9AKMT2AOXTR
Hydrochloric Acid SCHEMBL14721951 0.78 USP30 (0.45) KMT2A
SCHEMBL22858742 0.77 CNR2 (0.46) NPC1RAB9AKMT2ACNR2HPGD
SCHEMBL22858744 0.77 CNR2 (0.46) NPC1RAB9AKMT2ACNR2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021013083-A1 TRICYCLIC COMPOUNDS AS HPK1 INHIBITOR AND THE USE THEREOF BEIGENE, LTD. (KY) 2021-01-28 WO disclosed
WO-2021000925-A1 PYRROLO [2, 3-b] PYRAZINES AS HPK1 INHIBITOR AND THE USE THEREOF BEIGENE, LTD. (KY) 2021-01-07 WO disclosed